Factors Associated with HIV Status Disclosure and Its Effect on Treatment Adherence and Quality of Life among Children 6–17 Years on Antiretroviral Therapy in Southern Highlands Zone, Tanzania: Unmatched Case Control Study

Table 5

Crude and adjusted analysis for the association between HIV status disclosure and ART adherence, among children between 6 and 17 years on antiretroviral therapy in Southern Highlands Zone, Tanzania (N=309).

Variables	OR (95% CI)	P value	AOR (95% CI)	P value
HIV status disclosure:
No	Ref
Yes	4.545(1.029, 20.071)	<0.05	8.173(1.765, 37.842)	<0.05
Age of child:
6 – 9 years	Ref
10–13 years	0.349(2.042, 2.907)	0.330	0.288(0.034, 2.423)	0.252
14-17 years	0.189(0.024, 1.502)	0.115	0.095(0.011, 0.850)	<0.05
Caregivers education:
Primary or less	Ref
Secondary or high	1.578(0.509, 4.893)	0.430	1.825(0.543, 6.138)	0.331